MICROBIX BIOSYSTEMS INC (MBX.CA) Stock Analyst Earnings Estimates
TSX:MBX - Toronto Stock Exchange - CA59501P1045 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.08M 2.64% | 16.51M -13.47% | 25.394M 53.81% | 27.27M 7.39% | 37.067M 35.93% | 46.056M 24.25% | |
| EBITDA YoY % growth | 3.65M -35.28% | -1.58M -143.29% | 5.676M 459.23% | 5.959M 4.99% | 10.605M 77.97% | N/A | |
| EBIT YoY % growth | 2.61M -45.85% | -2.74M -204.98% | 4.063M 248.29% | 9.808M 141.39% | N/A | N/A | |
| Operating Margin | 13.68% | -16.60% | 16.00% | 35.97% | N/A | N/A | |
| EPS YoY % growth | 0.01 -79.31% | 0.02 166.67% | N/A 26.25% | 0.03 50.00% | 0.04 33.33% | 0.07 75.00% |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 0.04 488.89% | 0.00 | 0.04 | 3,565.35% |
| Q3 2023 Q2Q % growth | -0.01 -350.00% | 0.00 | -0.01 | % |
| Q2 2023 Q2Q % growth | 0.00 -100.00% | 0.00 | 0.00 | 100.00% |
| Q1 2023 Q2Q % growth | -0.01 -250.00% | 0.00 | -0.01 | -694.06% |
| Q4 2022 Q2Q % growth | -0.01 -190.00% | 0.00 | -0.01 | -456.44% |
| Q3 2022 Q2Q % growth | 0.00 -63.64% | 0.01 | 0.00 | -20.79% |
| Q2 2022 Q2Q % growth | 0.01 -28.57% | 0.01 | -0.01 | -58.75% |
| Q1 2022 Q2Q % growth | 0.01 500.00% | 0.01 | 0.00 | -40.59% |
| Q4 2021 Q2Q % growth | 0.01 120.00% | 0.01 | 0.00 | 10.01% |
| Q3 2021 Q2Q % growth | 0.01 375.00% | 0.01 | 0.00 | 55.59% |
| Q2 2021 Q2Q % growth | 0.01 275.00% | 0.00 | 0.01 | % |
| Q4 2020 Q2Q % growth | -0.05 | 0.01 | -0.06 | -595.05% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 6.044M -28.12% | % | ||
| Q4 2024 Q2Q % growth | 6.294M 47.60% | % | ||
| Q3 2024 Q2Q % growth | 5.059M -8.51% | % | ||
| Q2 2024 Q2Q % growth | 5.633M 33.54% | % | ||
| Q1 2024 Q2Q % growth | 8.408M 236.32% | % | ||
| Q4 2023 Q2Q % growth | 4.264M -1.52% | 4.848M | -583.77K | -12.04% |
| Q3 2023 Q2Q % growth | 5.53M 10.38% | 4.848M | 682K | 14.07% |
| Q2 2023 Q2Q % growth | 4.218M -13.57% | 4.141M | 77K | 1.86% |
| Q1 2023 Q2Q % growth | 2.5M -48.56% | 3.934M | -1.434M | -36.45% |
| Q4 2022 Q2Q % growth | 4.33M -23.09% | 5.318M | -988K | -18.58% |
| Q3 2022 Q2Q % growth | 5.01M -8.07% | 5.441M | -431K | -7.92% |
| Q2 2022 Q2Q % growth | 4.88M 12.18% | 5.985M | -1.105M | -18.46% |
| Q1 2022 Q2Q % growth | 4.86M 53.80% | 5.05M | -190K | -3.76% |
| Q4 2021 Q2Q % growth | 5.63M 107.75% | 6.262M | -632K | -10.09% |
| Q3 2021 Q2Q % growth | 5.45M 87.93% | 6.06M | -610K | -10.07% |
| Q2 2021 Q2Q % growth | 4.35M 51.57% | 3.833M | 517K | 13.49% |
| Q1 2021 Q2Q % growth | 3.16M 54.15% | 3.166M | -6K | -0.19% |
| Q4 2020 Q2Q % growth | 2.71M -24.51% | 4.689M | -1.979M | -42.21% |
| Q3 2020 Q2Q % growth | 2.9M -6.75% | 4.04M | -1.14M | -28.22% |
| Q2 2020 Q2Q % growth | 2.87M -32.47% | % | ||
| Q1 2020 Q2Q % growth | 2.05M -16.67% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 50% | 50% |
| Revenue | N/A | N/A | 9.31% | -7.22% |